~*K4',!Q5{~*P}P9ZDC&6A!%A~,0V@9C3){;
SYSTEM PROCESSING...
~*K4',!Q5{~*P}P9ZDC&6A!%A~,0V@9C3){;
SYSTEM PROCESSING...
Posted: 2025-06-12 05:54:18 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-06-12 05:54:28 UTC
Verified By
Rollup News
A study in mice suggests fibrate medications protect against cardiovascular disease by reducing inflammatory signaling in hepatocytes via PPAR-alpha, not by lowering lipids as previously believed.
Fibrate medications may protect against cardiovascular disease.
The protective mechanism may involve dampening inflammatory signaling in hepatocytes through PPAR-alpha.
The mechanism is different than previously thought.
Understanding the exact mechanisms by which fibrate medications protect against cardiovascular disease.